This finding underscores why personalized dosing strategiesinformed by your medical history and genetic profileoften outperform one-size-fits-all approaches
Semaglutide is a diabetes and anti-obesity medication that belongs to the glucagon-like peptide-1 GLP-1 receptor agonists class
This inhibition consecutively leads to post-prandial GLP-1 plasma concentrations that are elevated 2-3-fold and mediates the glucose-dependent stimulation of insulin secretion and inhibition of glucagon secretion (10, 19)
Parker-Athill E, Luo D, Bailey A, Giunta B, Tian J, Shytle RD, Murphy T, Legradi G, Tan J (2009) Flavonoids, a prenatal prophylaxis via targeting JAK2/STAT3 signaling to oppose IL-6/MIA associated autism
Image: Yummy Canine Scramble by Kimberly Gauthier / via Flickr
Because GIP receptor activation affects fat metabolism through pathways separate from appetite control, there is a theoretical basis for better weight maintenance at lower tirzepatide doses compared to equivalent semaglutide doses